News Releases

Anixa Biosciences Congratulates Scientific Advisory Board Member Dr. H. Michael Shepard as a 2019 Lasker Award Honoree

September 16, 2019

Anixa Biosciences to Present at Two Upcoming Investor Conferences

August 26, 2019

Anixa Biosciences Announces VA North Texas Health Care System to Join Cchek™ Prostate Cancer Study

July 29, 2019

Anixa Biosciences Announces Additional Patent Issued on Cancer Detection Technology

July 24, 2019

Anixa Biosciences Announces U.S. Department of Veterans Affairs VA Maryland Health Care System Joins Cchek™ Prostate Cancer Study

July 22, 2019

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

July 17, 2019

Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

July 16, 2019

Anixa Biosciences to Present at the CYTO 2019 - 34th Congress of the International Society for Advancement of Cytometry

May 29, 2019

Anixa Biosciences to Present at the Sachs Associates 5th Annual Immuno-Oncology BD&L and Investment Forum

May 21, 2019

Anixa Biosciences Announces Completion of Cchek™ Analytical Verification at CLIA Laboratory

May 13, 2019

Latest News & Events

Dec 8, 2022

Anixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine

Read More...

Nov 8, 2022

Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium

Read More...

Oct 31, 2022

Dr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy

Read More...